# Standard Biotools Inc.: Form 10-Q for the period ended Mar 31, 2014

- Company: [Standard Biotools Inc.](/companies/lab.md) (CIK 1162194)
- Form: 10-Q
- Filed: 2014-05-12
- Accepted by EDGAR: May 12, 2014, 17:06 ET
- Period: 2014-03-31
- Accession: 0001162194-14-000016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1162194/000116219414000016/q12014form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1162194/000116219414000016/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-01-01 to 2014-03-31 | $25.7m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2014-01-01 to 2014-03-31 | $8.7m | us-gaap:CostOfGoodsSold |
| Research and development | 3 months, 2014-01-01 to 2014-03-31 | $7.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2014-01-01 to 2014-03-31 | $15.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-01-01 to 2014-03-31 | −$16.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-01-01 to 2014-03-31 | $1.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-01-01 to 2014-03-31 | −$2.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-01-01 to 2014-03-31 | −$15.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-01-01 to 2014-03-31 | −$0.57 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2014-01-01 to 2014-03-31 | −$10.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2014-01-01 to 2014-03-31 | $1.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2014-03-31 | $101.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-03-31 | $178.8m | us-gaap:AssetsCurrent |
| Total assets | at 2014-03-31 | $424.7m | us-gaap:Assets |
| Current liabilities | at 2014-03-31 | $25.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-03-31 | $257.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2014-03-31 | $167.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1162194/000116219414000016/q12014form10-q.htm

Filed May 12, 2014.
Source: SEC EDGAR, the filing index for accession 0001162194-14-000016. Last ingested by Listed: Nov 5, 2026, 21:16 ET. No prices; not investment advice.
